TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Institutional Ownership & Insider Trading
671 institutions reported holding TEVA PHARMACEUTICAL INDUSTRIES LTD shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 58 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TEVATEVA PHARMACEUTICAL INDUSTRIES LTDFollow TEVA — free
—
Price chart with a free account
- Market cap
- 45.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters671 institutions held 63.0% of the shares. Across filers that reported both quarters, shares held changed +4.1%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 671 | 735 | +4.1% | 249 | 60 | 169 | 42 |
| Mar 26 | 645 | 672 | +3.2% | 212 | 70 | 182 | 48 |
| Dec 25 | 618 | 686 | -10.7% | 186 | 89 | 171 | 35 |
| Sep 25 | 533 | 728 | -1.7% | 153 | 60 | 147 | 48 |
| Jun 25 | 529 | 712 | -0.1% | 181 | 38 | 151 | 57 |
| Mar 25 | 545 | 711 | +7.2% | 175 | 55 | 164 | 72 |
| Dec 24 | 565 | 664 | +5.1% | 178 | 55 | 173 | 36 |
| Sep 24 | 529 | 621 | +0.3% | 166 | 55 | 153 | 50 |
TEVA PHARMACEUTICAL INDUSTRIES LTD — questions
- Who owns TEVA PHARMACEUTICAL INDUSTRIES LTD stock?
- 671 institutions reported TEVA PHARMACEUTICAL INDUSTRIES LTD shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (5.5%), Harel Insurance Investments & Financial Services Ltd. (4.1%), Phoenix Financial Ltd. (3.7%).
- Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders buying or selling?
- 58 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from TEVA PHARMACEUTICAL INDUSTRIES LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.